• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNA-195-5p/hnRNP A1 轴通过调节癌细胞的迁移促进肝癌的进展。

The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.

机构信息

Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea.

Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea; Department of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, 06591, South Korea.

出版信息

Biochem Biophys Res Commun. 2023 Dec 17;686:149183. doi: 10.1016/j.bbrc.2023.149183. Epub 2023 Oct 30.

DOI:10.1016/j.bbrc.2023.149183
PMID:37926044
Abstract

Dysregulation of gene expression is critical for the progression of cancer. The augmented expression of hnRNP A1 in patients with hepatocellular carcinoma (HCC) has been related to its oncogenic functions. However, the underlying mechanisms responsible for upregulation of hnRNP A1 have not been fully elucidated. In the present study, we identified microRNA-195-5p (miR-195-5p), a miRNA downregulated in HCC, as a novel regulator governing hnRNP A1 expression. Notably, our investigations showed an inverse correlation between hnRNP A1 level, which was increased in HCC, and miR-195-5p level, which was decreased. Our findings demonstrated that hnRNP A1 significantly enhanced the migration and invasion of PLC/PRF/5 cells through its association with mRNAs regulating metastasis. MiR-195-5p also interfered with the hnRNP A1-mediated cell migration by targeting hnRNP A1. Our results underscore the significance of the miR-195-5p/hnRNP A1 axis in regulating the migratory potential of cancer cells and its role in promoting HCC by orchestrating cell migration processes.

摘要

基因表达失调对癌症的进展至关重要。肝癌(HCC)患者中 hnRNP A1 的表达增加与其致癌功能有关。然而,导致 hnRNP A1 上调的潜在机制尚未完全阐明。在本研究中,我们确定了 microRNA-195-5p(miR-195-5p),一种在 HCC 中下调的 miRNA,作为调控 hnRNP A1 表达的新型调节剂。值得注意的是,我们的研究表明 hnRNP A1 水平与 miR-195-5p 水平呈负相关,hnRNP A1 水平在 HCC 中增加,而 miR-195-5p 水平则降低。我们的研究结果表明,hnRNP A1 通过与调节转移的 mRNA 结合,显著增强了 PLC/PRF/5 细胞的迁移和侵袭。miR-195-5p 还通过靶向 hnRNP A1 干扰 hnRNP A1 介导的细胞迁移。我们的研究结果强调了 miR-195-5p/hnRNP A1 轴在调节癌细胞迁移潜能中的重要性,以及通过协调细胞迁移过程在促进 HCC 中的作用。

相似文献

1
The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.miRNA-195-5p/hnRNP A1 轴通过调节癌细胞的迁移促进肝癌的进展。
Biochem Biophys Res Commun. 2023 Dec 17;686:149183. doi: 10.1016/j.bbrc.2023.149183. Epub 2023 Oct 30.
2
microRNA-mediated regulation of splicing factors SRSF1, SRSF2 and hnRNP A1 in context of their alternatively spliced 3'UTRs.microRNA 介导的剪接因子 SRSF1、SRSF2 和 hnRNP A1 的调控及其可变 3'UTR 。
Exp Cell Res. 2018 Feb 15;363(2):208-217. doi: 10.1016/j.yexcr.2018.01.009. Epub 2018 Jan 10.
3
MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.microRNA-769-5p 通过衰减 RYBP 促进肝癌细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2019 Oct;118:109343. doi: 10.1016/j.biopha.2019.109343. Epub 2019 Aug 13.
4
LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression.长链非编码 RNA ANCR 通过上调 HNRNPA1 表达促进肝癌转移。
RNA Biol. 2020 Mar;17(3):381-394. doi: 10.1080/15476286.2019.1708547. Epub 2020 Jan 2.
5
PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.PKM2 通过 let-7a-5p/Stat3/hnRNP-A1 调控反馈环促进乳腺癌细胞的糖代谢。
J Cell Biochem. 2019 Apr;120(4):6542-6554. doi: 10.1002/jcb.27947. Epub 2018 Oct 28.
6
MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.MicroRNA-1251-5p 通过靶向 AKAP12 促进肝癌的肿瘤生长和转移。
Biomed Pharmacother. 2020 Feb;122:109754. doi: 10.1016/j.biopha.2019.109754. Epub 2019 Dec 30.
7
MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.微小 RNA-98-5p 通过靶向核因子-κB 诱导激酶抑制乙型肝炎病毒相关肝细胞癌的发生。
Yonsei Med J. 2020 Jun;61(6):460-470. doi: 10.3349/ymj.2020.61.6.460.
8
MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.微小 RNA-486-5p 在肝癌中下调,通过靶向 PIK3R1 抑制肿瘤生长。
FEBS J. 2015 Feb;282(3):579-94. doi: 10.1111/febs.13167. Epub 2014 Dec 27.
9
MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.microRNA-183-5p 通过靶向 PDCD4 促进人肝癌的恶性进展。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20201761.
10
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.长链非编码 RNA AGAP2-AS1 作为竞争性内源性 RNA,通过海绵吸附 miR-16-5p 而上调 ANXA11 的表达,促进肝癌的增殖和转移。
J Exp Clin Cancer Res. 2019 May 14;38(1):194. doi: 10.1186/s13046-019-1188-x.

引用本文的文献

1
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications.m6A RNA甲基化调节剂在胰腺癌中的作用:相互作用及潜在影响
Cancer Cell Int. 2025 Aug 4;25(1):292. doi: 10.1186/s12935-025-03922-8.
2
MicroRNA 195, lactate dehydrogenase 5, phosphatase and tensin homologue in colorectal cancer: Clinicopathology and prognosis.微小RNA 195、乳酸脱氢酶5、磷酸酶和张力蛋白同源物在结直肠癌中的临床病理特征及预后分析
World J Gastrointest Surg. 2025 Jul 27;17(7):107121. doi: 10.4240/wjgs.v17.i7.107121.
3
The role of RNA binding proteins in cancer biology: A focus on FMRP.
RNA结合蛋白在癌症生物学中的作用:聚焦于脆性X智力低下蛋白(FMRP)
Genes Dis. 2024 Dec 21;12(4):101493. doi: 10.1016/j.gendis.2024.101493. eCollection 2025 Jul.
4
Identification of RNA-binding protein hnRNP C targeting the 3'UTR of the TAP-associated glycoprotein tapasin in melanoma.鉴定 RNA 结合蛋白 hnRNP C 靶向黑色素瘤中 TAP 相关糖蛋白 tapasin 的 3'UTR。
Oncoimmunology. 2024 Jun 27;13(1):2370928. doi: 10.1080/2162402X.2024.2370928. eCollection 2024.